ROYLE EENIGENBURG: Open Payments
NPI 1104858836 · JUNEAU, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125,927 in 297 payments from 16 companies in 2025. Trend: 2023 $55,519 · 2024 $47,094 · 2025 $125,927
Speaker / faculty: $85,203Consulting: $26,915Travel & lodging: $7,586Food & beverage: $6,001Education: $221
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 78 | $63,612 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $26,960 |
| Alkermes, Inc. | 48 | $20,609 |
| Teva Pharmaceuticals USA, Inc. | 26 | $12,844 |
| Lundbeck LLC | 28 | $456 |
| Vanda Pharmaceuticals Inc. | 17 | $350 |
| ABBVIE INC. | 17 | $323 |
| Otsuka America Pharmaceutical, Inc. | 9 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| Neurocrine BioSciences, Inc. | 8 | $139 |
Products named: COBENFY, CAPLYTA, LYBALVI, UZEDY, VIVITROL, REXULTI, VRAYLAR, FANAPT.
Industry payments across WI — which companies pay providers there.
